glp 1 and inflammatory arthritis Glucagon-like Peptide-1 Receptor Agonists in Rheumatoid Arthritis: A Scoping Review of Metabolic, Anti-Inflammatory, Cardioprotective Effects Targeting the GLP-1/GLP-1R axis to

Conditions like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), small intestinal bacterial overgrowth (SIBO), and leaky gut syndrome are not only common but often underdiagnosed or mismanaged

The SELECT trial demonstrated semaglutide reduces major adverse cardiovascular events by 20% in non-diabetic patients, repositioning GLP-1 drugs as disease-modifying therapies

Promotes working (short-term) memory Encourages quick thinking Supports overall cognitive health Also available in tropical punch flavored drink mix and in a convenient sugar-free* gummy *Not a low-calorie food

& Manning, B

Bourgeois S, Coenen S, Degroote L et al (2024) Harnessing beta cell regeneration biology for diabetes therapy